BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22190713)

  • 1. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.
    Andrei G; Topalis D; Fiten P; McGuigan C; Balzarini J; Opdenakker G; Snoeck R
    J Virol; 2012 Mar; 86(5):2641-52. PubMed ID: 22190713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
    Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
    Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.
    Morfin F; Thouvenot D; De Turenne-Tessier M; Lina B; Aymard M; Ooka T
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2412-6. PubMed ID: 10508017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.
    Talarico CL; Phelps WC; Biron KK
    J Virol; 1993 Feb; 67(2):1024-33. PubMed ID: 8380452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance testing of clinical varicella-zoster virus strains.
    Sauerbrei A; Taut J; Zell R; Wutzler P
    Antiviral Res; 2011 Jun; 90(3):242-7. PubMed ID: 21539861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides.
    Andrei G; Sienaert R; McGuigan C; De Clercq E; Balzarini J; Snoeck R
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1081-6. PubMed ID: 15728906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
    Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
    Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.
    Bleymehl K; Cinatl J; Schmidt-Chanasit J
    Med Microbiol Immunol; 2011 Aug; 200(3):193-202. PubMed ID: 21373931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific recognition of the bicyclic pyrimidine nucleoside analogs, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV-encoded thymidine kinase.
    Sienaert R; Naesens L; Brancale A; De Clercq E; McGuigan C; Balzarini J
    Mol Pharmacol; 2002 Feb; 61(2):249-54. PubMed ID: 11809847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades.
    Hoffmann A; Döring K; Seeger NT; Bühler M; Schacke M; Krumbholz A; Sauerbrei A
    J Clin Virol; 2017 Oct; 95():61-65. PubMed ID: 28886462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.
    Andrei G; Snoeck R; Reymen D; Liesnard C; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):318-29. PubMed ID: 7649195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.
    Coen N; Duraffour S; Topalis D; Snoeck R; Andrei G
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7312-23. PubMed ID: 25267682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of drug resistant mutants of varicella-zoster virus: cross resistance of acyclovir resistant mutants with phosphonoacetic acid and bromodeoxyuridine.
    Shiraki K; Ogino T; Yamanishi K; Takahashi M
    Biken J; 1983 Mar; 26(1):17-23. PubMed ID: 6312958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.
    Suzutani T; Ishioka K; De Clercq E; Ishibashi K; Kaneko H; Kira T; Hashimoto K; Ogasawara M; Ohtani K; Wakamiya N; Saijo M
    Antimicrob Agents Chemother; 2003 May; 47(5):1707-13. PubMed ID: 12709344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate.
    Brunnemann AK; Bohn-Wippert K; Zell R; Henke A; Walther M; Braum O; Maschkowitz G; Fickenscher H; Sauerbrei A; Krumbholz A
    Antimicrob Agents Chemother; 2015 May; 59(5):2726-34. PubMed ID: 25712361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.
    Fujii H; Harada S; Yoshikawa T; Yamada S; Omura N; Shibamura M; Inagaki T; Kato H; Fukushi S; Saijo M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
    Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
    J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir.
    Kamiyama T; Kurokawa M; Shiraki K
    J Gen Virol; 2001 Nov; 82(Pt 11):2761-2765. PubMed ID: 11602787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication.
    Balzarini J; McGuigan C
    J Antimicrob Chemother; 2002 Jul; 50(1):5-9. PubMed ID: 12096000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.